Search results
Results from the WOW.Com Content Network
According to new data from the Department of Health and Human Services, nearly 49 million Americans aged 12 or older reported having a substance use disorder in 2022. That number included some 29. ...
According to the Journal Citation Reports, the journal has a 2022 impact factor of 3.9. [2] It is thus ranked #11 out of 38 journals within the category of Substance Abuse. However, according to another metric, the TQCC (top quartile citation count), Journal of Substance Use and Addiction Treatment is ranked #1 in that category as of early 2024 ...
In the United States, there were approximately 109,600 drug-overdose-related deaths in the 12-month period ending January 31, 2023, at a rate of 300 deaths per day. [6] From 1999 to 2020, nearly 841,000 people died from drug overdoses, [7] with prescription and illicit opioids responsible for 500,000 of those deaths. [8]
Drug overdose deaths in the US per 100,000 people by state. [1] [2] A two milligram dose of fentanyl powder (on pencil tip) is a lethal amount for most people. [3] The United States Centers for Disease Control and Prevention (CDC) has data on drug overdose death rates and totals. Around 1,106,900 US residents died from drug overdoses from 1968 ...
Additionally, in 2014, Canada also allocated almost $45 million towards battling prescription drug abuse, extending into the year 2019. [95] Most of the financial decisions made on substance abuse in Canada can be attributed to the research conducted by the Canadian Centre on Substance Abuse (CCSA) which conduct both extensive and specific reports.
Using the program year estimates provided in the Contract as evidence of the bona fide need, NIDA must resolve these violations by deobligating $14.9 million ($20.2 million less $5.3 million) of fiscal year 2007 funds that were obligated in excess of the agency's bona fide need for program year 1 and obligating the appropriate fiscal year funds ...
A 2012 study conducted by the National Center on Addiction and Substance Abuse at Columbia University concluded that the U.S. treatment system is in need of a “significant overhaul” and questioned whether the country’s “low levels of care that addiction patients usually do receive constitutes a form of medical malpractice.”
The differences in the genetic regions encoding the dopamine receptors for each individual may help to elucidate part of the risk for opioid addiction and general substance abuse. [10] Studies of the D2 Dopamine Receptor, in particular, have shown some promising results. One specific SNP is at the TaqI RFLP (rs1800497).